Super Session 3 - Creative Partnering
Wednesday, September 14, 2016
•
S4
•
2:00 PM
>
3:00 PM
•
Super Session 3 - Creative Partnering
•
Plenary Room A3
Hosted by AstraZeneca
In the new life science landscape, big pharma is increasingly finding new ways to collaborate with small biotechs and academia in their pursuit to stay competitive and fill their pipelines. Innovation is a necessity for developing new products and in this session, we want to bring innovation into the process of partnering itself. Areas for discussion include how to run successful negotiations and the role of creativity, together with more hands-on questions such as what needs to be considered before entering into a negotiation, how to handle IP sensibly and when and how should you announce a deal.
Moderator: Mr. Vincent Bergeron, Director, Business Development, Voisin Consulting Life Sciences
Speakers:
Dr. Christoph Pittius, Vice President, Head of Transactions, AstraZeneca
Dr. Matthew Roden, Head of Strategic Corporate Development, Bristol-Myers Squibb
Ms. Susanne Ås Sivborg, Director General, The Swedish Patent and Registration Office (PRV)
Dr. Jørgen Drejer, CEO, Saniona
|